Videos LOC in HCA UK at University College Hospital (HCA)

An insight into cancer treatments available to patients in the UK and how effective they are See more

In this online interview, Professor Andrew Wardley, a highly experienced and qualified consultant medical oncologist and breast cancer specialist, discusses the latest cancer treatments available to patients living with cancer in the UK, and tells us just how effective they are. If you would like to book an appointment with Professor Wardley today, visit his Top Doctors profile here: https://www.topdoctors.co.uk/doctor/andrew-wardley ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

What are the most effective targeted therapies for lung cancer? - Online interview See more

In this online interview, highly experienced consultant medical oncologist, Dr Dionysis Papadatos-Pastos, explains in detail some of the most effective targeted therapies for lung cancer. 00:00 Introduction 00:08 What are the most effective targeted therapies for lung cancer? 00:54 What are some of the most common ones? 02:29 With effective therapy, what is the expected prognosis of the lung cancer patient? 03:53 Is targeted therapy the first treatment option recommended for lung cancer patients? To book an appointment with Dr Dionysis Papadatos-Pastos today, simply visit his Top Doctors profile here today: https://www.topdoctors.co.uk/doctor/dionysis-papadatos-pastos ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

An introduction to Dr Dionysis Papadatos-Pastos See more

We introduce Dr Dionysis Papadatos-Pastos, renowned consultant medical oncologist, who specialises in the treatment of thoracic cancers including lung cancer, mesothelioma and thymoma. 00:00 What is your name and position? 00:11 Why did you decide to become a doctor? 01:00 What made you choose your specialty? 01:41 What do your patients value most about you? 02:08 What do you value most about your patients? 02:30 Do you have any mantra or catchphrase that you use in your work? If you would like to book an appointment with Dr Papadatos-Pastos, head on over to his Top Doctors profile here today: https://www.topdoctors.co.uk/doctor/dionysis-papadatos-pastos ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

Career in Medical...Dr Hendrik-Tobias Arkenau, Medical Director at SCRI U See more

Dr Hendrik-Tobias Arkenau is the medical director of Sarah Cannon Research Institute UK, a stand-alone clinical trial facility dedicated to developing new anti-cancer drugs and therapies. On a daily basis, Dr Arkenau works closely with his team to ensure a high standard of care and treatment is provided to patients, and clinical trial data is delivered timely and accurately to research partners in the pharmaceutical industry. Watch full video on http://www.10minuteswith.com/interview/dr-hendrik-tobias-arkenau-medical-director-scri-uk

Dr Hendrik-Tobias Arkenau See more

Dr. Arkenau has vast experience in early oncology clinical drug development with a special interest in gastrointestinal cancer and melanoma. He received his medical degree in 2000 at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. Before joining Sarah Cannon Research UK, he was senior clinical fellow at the Royal Marsden Hospital and team leader for early drug development at the Prince of Wales Clinical School at the University of New South Wales, Sydney, Australia.

Dr. Arkenau on Advancements on Horizon in Gastric Cancer See more

Hendrik-Tobias Arkenau, MD, PhD, founding medical director, executive medical director, Sarah Cannon Research Institute UK, discusses immunotherapy advancements on the horizon as potential treatments for patients with gastric cancer.

Dr. Arkenau Discusses the Future of Immunotherapy in Melanoma See more

Hendrik-Tobias Arkenau, MD, PhD, executive medical director, Drug Development Unit, Sarah Cannon Research Institute-United Kingdom, discusses the future of immunotherapy in melanoma. In the past, the initial successful data of CTLA-4 blockade with ipilimumab resulted in a response rate of about 10%. Today, there are combinations with ipilumumab and evolumab, with response rates in the range of 60%, so there have been very strong results. Arkenau says it is exciting that the response rates are improving with these combinations and result in prolonged progression-free survival.

Dr. Arkenau on the Potential of Immunotherapy in Gastric Cancer See more

Dr Hendrik Tobias Arkenau See more

Dr. Arkenau on Survival Data With TAS-102 in Gastric Cancer See more

Immunotherapy clinical trials for cancer patients See more

Dr Hendrik Tobias Arkenau, a leading medical oncologist from the renowned Sarah Cannon Research Institute in London, explains what cancer clinical trials involve, and more specifically what immunotherapy clinical trials are like. He also explains how cancer patients should go about requesting information about active clinical trials, should they be suitable for inclusion. Book an appointment with Dr Arkenau here: https://www.topdoctors.co.uk/doctor/h...

How does immunotherapy work? See more

Immunotherapy is a type of cancer treatment that aims to manipulate the way our own immune system recognises and fights cancer cells. Dr Hendrik Tobias Arkenau, a prominent medical oncologist from the Sarah Cannon Research Insitute in London, explains in more detail what cancer immunotherapy is and how it differs to other cancer treatments, such as chemotherapy. Book a consultation with Dr Arkenau: https://www.topdoctors.co.uk/doctor/h...

What are the side effects of immunotherapy? See more

Immunotherapy for cancer treatment can sometimes produce certain side effects. However, these side effects are very different to those of other cancer treatments, such as chemotherapy, and are generally more of an inflammatory nature, which could affect any part of the body. Dr Hendrik Tobias Arkenau, a leading medical oncologist at the Sarah Cannon Research Institute in London, explains in more detail the possible side effects of immunotherapy and what patients should do if they experience them. Book a consultation with Dr Arkenau: https://www.topdoctors.co.uk/doctor/h...

How successful is immunotherapy? See more

Immunotherapy cancer treatment in the last 10 years has shown great success in a variety of different types of cancer. Dr Hendrik Tobias Arkenau, a leading medical oncologist at the Sarah Cannon Research Institute in London, explains the success we've seen so far with immunotherapies, and also what the future of immunotherapy cancer treatment holds. Book an appointment now with Dr Arkenau: https://www.topdoctors.co.uk/doctor/h...

How is anaemia managed? See more

Anaemia is a fairly common condition that has a number of different possible causes, such as iron deficiency. Dr Jaimal Kothari discusses the condition, what can cause it, and how it can be managed. If you have anaemia, and would like expert treatment from Dr Kothari, request an appointment here: https://www.topdoctors.co.uk/doctor/jaimal-kothari ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

What are the causes of lymphadenopathy? See more

Lymphadenopathy is a disease that causes the lymph glands to become swollen and tender to the touch. Consultant haematologist, Dr Jaimal Kothari explains more about lymphadenopathy, and how it is treated. If you have swollen glands, and would like to be checked for lymphadenopathy, book an appointment with Dr Kothari here: https://www.topdoctors.co.uk/doctor/jaimal-kothari ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

What is chronic lymphocytic leukaemia? See more

Chronic lymphocytic leukaemia is a type of blood cancer that is very treatable. Consultant haematologist, Dr Jaimal Kothari explains more about the condition. If you would like to have a consultation with Dr Kothari, book here: https://www.topdoctors.co.uk/doctor/jaimal-kothari ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

Multiple myeloma: who does it affect, and what are the treatment options? See more

Multiple myeloma is a type of cancer that forms in the antibody-creating plasma cells. Dr Jaimal Kothari explains how multiple myeloma is diagnosed, who it affects, and what the treatment options are. If you're concerned about multiple myeloma, or have a diagnosis and would like to discuss the treatment options with Dr Kothari, you can request an appointment here: https://www.topdoctors.co.uk/doctor/jaimal-kothari ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh

Webinar Clinical Trials 050621 See more

Dr Jaimal Kothari joined us to provide insights on clinical trials.

All you need to know about bone marrow transplant procedures - Online interview See more

Just what exactly does a bone marrow transplant involve and when might the procedure be required? On hand in our latest online interview to answer these questions and more is highly skilled London-based consultant haemotologist, Dr Varun Mehra. If you are considering undergoing a bone marrow transplant and are seeking further information, you can consult directly with Dr Mehra by booking an appointment with him via his Top Doctors profile here: https://www.topdoctors.co.uk/doctor/varun-mehra ✔  Follow us on Instagram: https://bit.ly/3fSrqXb ✔  Follow us on Facebook: https://bit.ly/3t5kGsW ✔  Follow us on Twitter: https://bit.ly/39TidKh